Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
23.00
-0.37 (-1.58%)
At close: Apr 28, 2026, 4:00 PM EDT
23.31
+0.31 (1.35%)
After-hours: Apr 28, 2026, 6:48 PM EDT
AAPG Stock Forecast
Stock Price Forecast
The 5 analysts that cover AAPG stock have a consensus rating of "Strong Buy" and an average price target of $48.4, which forecasts a 110.43% increase in the stock price over the next year. The lowest target is $45 and the highest is $51.
Price Target: $48.4 (+110.43%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AAPG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 2 | 3 | 3 | 3 | 3 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Reiterates $48 | Strong Buy | Reiterates | $48 | +108.70% | Apr 13, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $48 | Strong Buy | Reiterates | $48 | +108.70% | Mar 26, 2026 |
| BTIG | BTIG | Strong Buy Initiates $48 | Strong Buy | Initiates | $48 | +108.70% | Mar 12, 2026 |
| Oppenheimer | Oppenheimer | Buy Initiates $45 | Buy | Initiates | $45 | +95.65% | Dec 4, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $51 | Strong Buy | Initiates | $51 | +121.74% | Nov 24, 2025 |
Financial Forecast
Revenue This Year
2.24B
from 574.12M
Increased by 290.34%
Revenue Next Year
1.88B
from 2.24B
Decreased by -16.20%
EPS This Year
1.21
from -3.49
EPS Next Year
-0.35
from 1.21
Financial currency is CNY. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 3.3B | 3.2B | ||||||
| Avg | 2.2B | 1.9B | ||||||
| Low | 829.1M | 1.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 477.2% | 41.5% | ||||||
| Avg | 290.3% | -16.2% | ||||||
| Low | 44.4% | -55.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 4.84 | 3.44 | |||
| Avg | 1.21 | -0.35 | |||
| Low | -2.98 | -1.73 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 183.9% | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.